ESC Professional Premium Access

Statin therapy: clinical role and current challenges

Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session type: Moderated ePosters
Date: 26 August 2022
Time: 16:15 - 16:55

Congress Session

6 presentations in this session

Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data

Speaker: Doctor M. Abdelghani (Doha, QA)
Thumbnail

The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients

Speaker: Doctor A. Halili (Copenhagen, DK)
Thumbnail

Statin use and cardiovascular outcomes after myocardial infarction: a population-based case-control study

Speaker: Doctor V. Kyto (Turku, FI)
Thumbnail

Perioperative rosuvastatin therapy increases creatine kinase and the risk of acute kidney injury in patients undergoing cardiac surgery

Speaker: Doctor R. Wijesurendra (Oxford, GB)
Thumbnail

Use of statins in cancer patients following acute myocardial infarction and its impact on long-term clinical outcomes.

Speaker: Doctor K. Stepien (Krakow, PL)
Thumbnail

Drucebo effect in statin therapy: more attributable to the patient, the doctor, or the mass media?

Speaker: Doctor D. Cosmi (Perugia, IT)
Thumbnail

6 speakers from this session

Doctor Mohamed Salah Abdelghani

Hamad Medical Corporation Heart Hospital, Doha (Qatar)
1 presentation
0 follower

Doctor Andrim Halili

Bispebjerg Hospital, Copenhagen (Denmark)
0 follower

Doctor Ville Kyto

Turku University Hospital, Turku (Finland)
0 follower

Doctor Rohan Wijesurendra

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
5 presentations
0 follower

Doctor Konrad Stepien

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)
0 follower

Doctor Deborah Cosmi

Gubbio-Gualdo Tadino Hospital, Perugia (Italy)
0 follower

This platform is supported by

logo Novo Nordisk